Results 1 to 10 of about 1,794,069 (258)

Oral Candidiasis: A Disease of Opportunity [PDF]

open access: yesJournal of Fungi, 2020
Oral candidiasis, commonly referred to as “thrush,” is an opportunistic fungal infection that commonly affects the oral mucosa. The main causative agent, Candida albicans, is a highly versatile commensal organism that is well adapted to its human host ...
T. Vila   +3 more
semanticscholar   +4 more sources

An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study

open access: yesBMC Oral Health, 2021
Background Oral candidiasis is a common problem associated with head and neck radiation therapy (RT) consequences being pain, burning sensation, taste change, and systemic infection.
Imjai Chitapanarux   +6 more
doaj   +2 more sources

Miconazole in Oral Candidiasis [PDF]

open access: bronzeProceedings of the Royal Society of Medicine, 1977
Twenty-four patients were treated with oral miconazole (250 mg) for a total of 35 episodes of oral candidiasis. Sixteen had various forms of leukaemia and all were massively predisposed to fungal infection because of granulocytopenia and treatment with prednisolone and antibiotics.
H Brincker
openalex   +4 more sources

Oral Candidiasis in Adult and Pediatric Patients with COVID-19. [PDF]

open access: yesBiomedicines, 2023
Oral Candidiasis (OC) is an opportunistic fungal infection of the oral cavity, frequently reported under local and systemic predisposing circumstances. While the recurrence of OC HIV-infected subjects has been well described and reported, the association
Pisano M   +5 more
europepmc   +2 more sources

Biomaterials for the Prevention of Oral Candidiasis Development [PDF]

open access: yesPharmaceutics, 2021
Thousands of microorganisms coexist within the human microbiota. However, certain conditions can predispose the organism to the overgrowth of specific pathogens that further lead to opportunistic infections.
D. Gheorghe   +3 more
semanticscholar   +5 more sources

Isolation of Candida africana in oral candidiasis: First report among cancer patients in Iran [PDF]

open access: yesCurrent Medical Mycology, 2020
Background and Purpose: Oropharyngeal candidiasis (OPC) is a fungal infection of the oral cavity caused by the members of C. albicans complex. Although C.
Ensieh lotfali   +6 more
doaj   +2 more sources

The prevalence, risk factors and antifungal sensitivity pattern of oral candidiasis in HIV/AIDS patients in Kumba District Hospital, South West Region, Cameroon

open access: yesThe Pan African Medical Journal, 2020
INTRODUCTION: oral candidiasis is one of the most common opportunistic infection in HIV/AIDS patient and it is caused by Candida species. The low absolute CD4+T-lymphocyte count has traditionally been cited as the greatest risk factor for the development
Ngwa Fabrice Ambe   +7 more
doaj   +2 more sources

Mycotic infections – mucormycosis and oral candidiasis associated with Covid-19: a significant and challenging association

open access: yesJournal of Oral Microbiology, 2021
Introduction Bacterial and fungal secondary infections following COVID-19 disease are widely being reported and are an area that should receive careful attention.
Manjusha Nambiar   +5 more
doaj   +2 more sources

Clinical features and risk factors for Sjogren’s syndrome patients suffering from oral candidiasis in Shanxi, China [PDF]

open access: yesBMC Oral Health
Objectives To investigate the clinical features and risk factors of Sjogren’s Syndrome (SS) patients suffering from oral candidiasis and to provide a foundation for the prevention and treatment of oral candidiasis in SS patients.
Yexing Xing   +3 more
doaj   +2 more sources

Integrated Analysis of Clinical and Microbiome Risk Factors Associated with the Development of Oral Candidiasis during Cancer Chemotherapy

open access: yesJournal of Fungi, 2019
Oral candidiasis is a common side effect of cancer chemotherapy. To better understand predisposing factors, we followed forty-five subjects who received 5-fluorouracil- or doxorubicin-based treatment, during one chemotherapy cycle.
Patricia I. Diaz   +11 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy